ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2672

Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States

George A. Karpouzas1, Taylor Draper2, Elizabeth Hernandez1 and Sarah Ormseth1, 1Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Psychology, Loma Linda University, Loma Linda, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Disease Activity, patient outcomes, physician data and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients and
physicians often differ in their perceptions of disease activity in Rheumatoid arthritis (RA) as described
by patients’ and evaluators’ global assessments (PGA and EGA respectively),
mostly assessed in Caucasians. We evaluated determinants of PGA and EGA and
their proportionate contributions in Latinos with RA in the US. We further
explored predictors of discrepancies between PGA and EGA, and interrogated the
frequencies of concordant and discordant assessments of changes in PGA and EGA
longitudinally.

Methods: We assessed
333 Latinos with RA and follow up in a single center. EGA and PGA were captured
on a 0-10 cm visual analogue scale; discordance was defined as difference >2
cm between the 2 assessments. Linear regression models evaluated predictors of PGA
and EGA, and relative importance weights were calculated for their
proportionate contribution to PGA and EGA variance. Logistic regression models interrogated
predictors of both patient and physician higher ratings respectively.

Results: Our models explained 66% of variability in PGA and 83% of the
variability in EGA. Main, multivariate determinants for PGA were fatigue
(23.7%), pain (21.2%), depression (18%), and sedimentation rate- ESR (3.2%).
EGA was mainly predicted by swollen joint counts (44.4%), tender joint counts
(30.2%), ESR (5.2%) and fatigue (3.5%). Concordance was observed in 142 (43%),
higher patient ratings in 147 (44%), and higher physician ratings in 44 (13%). Fatigue
and pain predicted higher patient ratings, while swollen joints, tender joints,
and prednisone use predicted higher physician ratings (table 1). At follow up,
EGA improved in 31.7%, remained unchanged in 50.9% and worsened in 17.4%.
Respective trends for PGA were 28.6%, 44.1% and 27.3%. The lowest concordance
was seen for worsening disease, where PGA showed only 27% concordance with the
EGA, compared to 59% and 52% for unchanged or improved disease respectively.

Conclusion: Highly
divergent parameters shape patients’ and physicians’ perceptions of disease
activity in Latinos with RA in the US; fatigue and pain contribute mainly to
higher patient assessments, while swollen and tender joint counts predict
higher physician assessments. Patient education of what determines long-term disability,
and a better physician grasp of the patient perspective will likely foster
shared decision-making and compliance with treat to target initiative.

Table 1: Predictors
of discordant Patient –Physician Assessments of global disease activity

Higher PGA (PGA – EGA > 2cm)

Higher EGA (EGA – PGA > 2cm)

Unadjusted OR (95% CI)

Adjusted OR (95% CI)

Unadjusted OR (95% CI)

Adjusted OR (95% CI)

Age

1.02

(1.00 -1.04)

1.01

(0.98 -1.04)

Gender

1.29

(0.61 -2.73)

0.86

(0.32 -2.34)

Disease duration

0.98

(0.95 -1.01)

0.99

(0.95 -1.03)

RF positive

0.46

(0.19 -1.09)

0.32

(0.11 -0.93)

0.56

(0.11 -2.81)

CCP positive

0.64

(0.31 -1.34)

0.53

(0.20 -1.43)

Erosions

1.04

(0.66 -1.65)

1.61

(0.80 -3.23)

IAD present

1.25

(0.75 -2.10)

0.72

(0.31 -1.63)

Fibromyalgia

1.87

(1.01 -3.48)

0.90

(0.38-2.10)

0.47

(0.13 -1.68)

n-TJC

0.94

(0.89 -0.99)

0.87

(0.79 -0.95)**

1.21

(1.13 -1.29)

1.16

(1.05 -1.28)**

n-SJC

0.80

(0.73 -0.88)

0.64

(0.54 -0.75)***

1.38

(1.25 -1.52)

1.34

(1.18 -1.53)***

ESR

1.00

(0.99 -1.01)

1.02

(1.00 -1.03)

1.00

(0.98 -1.02)

Prednisone

1.23

(0.75 -2.02)

3.13

(1.56 – 6.29)

3.14

(1.15 -8.55)*

n-DMARDs

0.97

(0.77 -1.23)

0.81

(0.57 – 1.14)

Biologics

1.17

(0.73 -1.88)

1.63

(0.83 – 3.22)

HAQ-DI

1.80

(1.35 -2.41)

1.31

(0.84-2.04)

1.72

(1.16 – 2.57)

1.21

(0.61 -2.4)

Pain-VAS

2.07

(1.53 -2.79)

2.06

(1.23 -3.46)***

1.55

(1.01 – 2.38)

0.29

(0.12 -0.69)**

PHQ-9

1.10

(1.06 -1.15)

1.05

(0.99 -1.12)

1.02

(0.96 -1.08)

FACIT

1.26

(1.16 -1.37)

1.30

(1.12 -1.49)***

1.09

(0.97 -1.22)

*p<0.05, **p<0.01, ***p<0.001


Disclosure: G. A. Karpouzas, None; T. Draper, None; E. Hernandez, None; S. Ormseth, None.

To cite this abstract in AMA style:

Karpouzas GA, Draper T, Hernandez E, Ormseth S. Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/determinants-of-patient-physician-discordance-in-assessment-of-global-disease-activity-in-latinos-with-rheumatoid-arthritis-in-the-united-states/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/determinants-of-patient-physician-discordance-in-assessment-of-global-disease-activity-in-latinos-with-rheumatoid-arthritis-in-the-united-states/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology